Ms Angela Farr
Research Assistant
Swansea Centre for Health Economics
Telephone: (01792) 602135
Room: SCHE - 218
Second Floor
Vivian Building
Singleton Campus

Angela is an experienced analyst of health services and outcomes research having completed several National Institute for Health Research (NIHR) funded trials. Key areas of work include analysis of national routine ‘real world’ datasets such as NHS primary and secondary healthcare data and health economic evaluation of health technology assessments, clinical trials and broader healthcare evaluations. Evaluation techniques include cost-effectiveness analysis; QALY based cost-utility, cost-consequence, within trial budget impact analysis alongside modelling of health outcomes such as bootstrapping, cost calculator models for budget impact analysis of new treatments at UK national level and decision modelling.

Recent projects have included the following;

A randomised controlled trial with the Foot Ulcer Trails Unit, Nottingham University Hospitals NHS Trust- The evaluation of the effectiveness and cost-effectiveness of lightweight fibreglass heel casts in the management of ulcers of the heel in diabetes using data collected directly from the patient cohort.

Asthma UK Priority Needs Grant Project - Estimating the incidence, prevalence, healthcare utilisation, wider societal impact and true cost of asthma in the UK using ‘real world’ NHS routine data from the SAIL databank. A multi-centre evaluation working in partnership with researchers based in Edinburgh University and St George’s, University of London. 


  1. & Feasibility and economic assessment of chromocolonoscopy for detection of proximal serrated neoplasia within a population-based colorectal cancer screening programme (CONSCOP): an open-label, randomised controlled non-inferiority trial. The Lancet Gastroenterology & Hepatology 4(5), 364-375.
  2. et. al. Effects and costs of implementing predictive risk stratification in primary care: a randomised stepped wedge trial. BMJ Quality & Safety, bmjqs-2018-007976
  3. & (2018). OTU-026 Feasibility & economic evaluation – chromoendoscopy for detecting proximal serrated neoplasia: randomised controlled trial, conscop.. Presented at Gut,(Suppl 1), A184 UK: British Society of Gastroenterology. doi:10.1136/gutjnl-2018-BSGAbstracts.366
  4. & The development of a collaborative framework for commissioning health and social care. Journal of Integrated Care
  5. & Tu2012 - Feasibility and Economic Evaluation of Chromoendoscopy for Detecting Proximal Serrated Neoplasia in a Colorectal Cancer Screening Program: A Randomised Control Trial – Conscop. Gastroenterology 154(6), S-1369

See more...


There is a problem with one of the content items on this page. The affected component type is:


The system reports the following message:

406 Not Acceptable